| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 147.42B | 148.48B | 142.79B | 138.06B | 128.60B | 120.96B |
| Gross Profit | 50.61B | 50.57B | 50.46B | 51.93B | 50.81B | 47.73B |
| EBITDA | 11.87B | 12.40B | 15.55B | 15.10B | 17.41B | 16.82B |
| Net Income | 1.74B | 2.71B | 8.07B | 9.04B | 10.15B | 8.90B |
Balance Sheet | ||||||
| Total Assets | 169.71B | 177.46B | 175.69B | 169.34B | 161.84B | 147.63B |
| Cash, Cash Equivalents and Short-Term Investments | 21.49B | 26.48B | 26.70B | 32.74B | 44.21B | 39.69B |
| Total Debt | 16.14B | 16.18B | 15.15B | 15.48B | 15.50B | 15.83B |
| Total Liabilities | 50.15B | 53.29B | 49.38B | 49.71B | 50.66B | 45.94B |
| Stockholders Equity | 120.11B | 124.69B | 126.69B | 119.88B | 111.47B | 102.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.06B | 1.03B | -4.54B | 7.53B | 4.96B |
| Operating Cash Flow | 0.00 | 10.41B | 6.92B | 5.54B | 14.99B | 15.81B |
| Investing Cash Flow | 0.00 | -3.04B | -6.04B | -12.62B | -7.78B | -11.16B |
| Financing Cash Flow | 0.00 | -8.01B | -7.12B | -4.89B | -3.21B | -1.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥34.87B | 7.75 | ― | 3.59% | 7.84% | 29.36% | |
73 Outperform | ¥45.76B | 8.17 | ― | 3.74% | 4.73% | 17.57% | |
66 Neutral | ¥105.38B | 13.03 | ― | 3.53% | -1.02% | -40.96% | |
66 Neutral | ¥124.47B | 10.42 | 12.89% | 3.40% | 2.68% | 23.60% | |
64 Neutral | ¥61.36B | 20.20 | ― | 1.49% | -5.37% | -25.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥477.77B | -31.80 | 1.44% | 4.80% | 0.40% | 306.91% |